The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers
Éva Compérat(Vienna General Hospital), Victor Reuter(Memorial Sloan Kettering Cancer Center), Kiril Trpkov(University of Calgary), Henning Reis(Goethe University Frankfurt), Guido Dalbagni(Memorial Sloan Kettering Cancer Center), Maria Rosaria Raspollini(Azienda Ospedaliero-Universitaria Careggi), Hikmat Al‐Ahmadie(Unknown), Cristina Magi‐Galluzzi(University of Alabama at Birmingham), Dilek Bayder(Koç University), Adeboye O. Osunkoya(Emory University), Gladell P. Paner(University Health Network), Ondřej Hes(Charles University), Sounak Gupta(Mayo Clinic), Jesse K. McKenney(Cleveland Clinic), Jonathan E. Rosenberg(Memorial Sloan Kettering Cancer Center), Fadi Brimo(McGill University Health Centre), Jennifer Gordetsky(Bipar), Jonathan I. Epstein(Johns Hopkins University), Seema Kaushal(All India Institute of Medical Sciences), Rajal B. Shah(University of Michigan–Ann Arbor), Gopa Iyer(Memorial Sloan Kettering Cancer Center), George J. Netto(University of Pennsylvania), Morgan Rouprêt(Sorbonne Université), Kristina Pivovarcikova(Charles University), Chin Pan, Veronika Weyerer(Friedrich-Alexander-Universität Erlangen-Nürnberg), Trinity J. Bivalacqua(University of Pennsylvania), Sara M. Falzarano(University of South Florida), Shahrokh F. Shariat(Universitätszahnklinik Wien), John C. Cheville(Mayo Clinic), Larry True(University of Washington), Andrés Matoso(Johns Hopkins University), Ming Zhou(Indiana University School of Medicine), Mahul B. Amin(Ontario Institute for Cancer Research), Lakshmi P. Kunju(University of Michigan), Donna E. Hansel(The University of Texas MD Anderson Cancer Center), Liang Cheng(Beihang University), Charles C. Guo(The University of Texas MD Anderson Cancer Center)
Cited by 58
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Pan-cancer analysis of whole genomes
|Nature|2020|3.3k